Infinium Pharmachem Ltd
Pharmaceuticals & Biotechnology | Small Cap
Infinium Pharmachem Ltd demonstrates a mixed financial performance. The company excels in solvency and profitability, indicating a strong ability to meet long-term obligations and generate profits. Growth prospects are also promising, driven by robust revenue and asset expansion. However, liquidity faces challenges due to negative operating cash flow, and efficiency is hampered by inventory and capital turnover issues. Financial metrics like earnings per share and book value per share raise concerns. While coverage of interest expenses is adequate, the absence of dividend coverage is notable. The company's strengths in profitability and solvency are partially offset by weaknesses in liquidity and efficiency, requiring attention to optimize working capital and improve operational performance. Overall, the company exhibits a blend of financial strengths and areas needing improvement for sustained growth and stability.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio8.00
- Financial Ratio3.20
- Profitability Ratio10.00
- Efficiency Ratio4.33
- Coverage Ratio6.80
- Solvency Ratio10.00
- Liquidity Ratio6.38
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourBullish
- 2 HoursBullish
- 4 HoursBullish
- 1 DayBullish
- 1 WeekBearish
- 1 MonthNeutral
Infinium Pharmachem Ltd demonstrates a mixed financial performance. The company excels in solvency and profitability, indicating a strong ability to meet long-term obligations and generate profits. Growth prospects are also promising, driven by robust revenue and asset expansion. However, liquidity faces challenges due to negative operating cash flow, and efficiency is hampered by inventory and capital turnover issues. Financial metrics like earnings per share and book value per share raise concerns. While coverage of interest expenses is adequate, the absence of dividend coverage is notable. The company's strengths in profitability and solvency are partially offset by weaknesses in liquidity and efficiency, requiring attention to optimize working capital and improve operational performance. Overall, the company exhibits a blend of financial strengths and areas needing improvement for sustained growth and stability.
Overall Valuation Score
P/E RATIO (TTM)
32.63
Industry Median
28.62
Small Cap Median
27.17
P/E RATIO
26.90
P/B RATIO
2.70
Industry Median
3.17
Small Cap Median
2.62
P/S RATIO
1.90
Industry Median
3.42
Small Cap Median
2.55
Others
PEG RATIO
0.75
EV/EBITDA RATIO
13.79
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹209.8 as on Jun 20, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
The growth ratios reveal a strong expansion in revenue and assets, but challenges in earnings per share and net income growth. The robust revenue growth rate and asset growth rate indicate successful market penetration and investment in new opportunities. However, the decline in earnings per share and net income growth needs attention to ensure profitability keeps pace with revenue. While the company is expanding, sustainable profitability must be a key focus.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 39.44 | 15.15 | 19.3 | 14.71 | 21.79 |
| Operating Profit Growth Rate | 100 | 60 | 18.75 | 0 | 15.79 |
| Earnings Per Share (EPS) Growth | 124.63 | -69.56 | -12.69 | -35.59 | 49.14 |
| Asset Growth Rate | 73.53 | 20.34 | 19.72 | 132.94 | -11.62 |
| Net Income Growth Rate | 133.33 | 42.86 | 20 | -33.33 | 75 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The financial ratios indicate significant challenges in key per-share metrics. The low adjusted earnings per share, cash earnings per share, and book value per share raise concerns about profitability and shareholder value. Additionally, the company does not distribute any dividends. While capital expenditures are at an average level, the overall financial performance needs improvement to enhance shareholder returns. Improving fundamental financial metrics is crucial for long-term value creation.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 75.8 | 20.66 | 8.71 | 6 | 10.03 |
| Cash Earnings Per Share (Cash EPS) | 80 | 22 | 10.71 | 6.88 | 10.62 |
| Book Value Per Share | 130 | 44 | 42.14 | 68.75 | 75.62 |
| Dividend Per Share (DPS) | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures (CapEx) | 4.7 | 7.5 | 3.5 | 8.7 | 9.7 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The profitability ratios collectively highlight an excellent ability to generate profits. High gross profit margin, return on capital employed, return on equity, return on assets, operating margin, and net margin all point to efficient operations and effective cost management. These strong profitability metrics provide a solid foundation for future growth and shareholder value creation. The company is performing remarkably well in terms of profitability.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 9.09 | 13.16 | 11.76 | 10.26 | 10 |
| Return on Capital Employed (ROCE) | 38 | 36 | 28 | 15 | 13 |
| Return on Equity (ROE) | 53.85 | 45.45 | 20.34 | 7.27 | 11.57 |
| Return on Assets (ROA) | 16.95 | 22.54 | 22.35 | 9.6 | 12.57 |
| Operating Margin | 10.1 | 14.04 | 13.97 | 12.18 | 11.58 |
| Net Margin | 7.07 | 8.77 | 8.82 | 5.13 | 7.37 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The efficiency ratios present a mixed view of the company's operational performance. While the fixed asset turnover ratio is above average, indicating efficient use of fixed assets, the inventory turnover and capital turnover ratios are weak, suggesting inefficiencies in inventory management and overall capital utilization. The high days sales in inventory and receivable days further highlight these inefficiencies. Optimizing inventory and capital management is essential for improving overall efficiency.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 24.75 | 6 | 6.8 | 6.5 | 8.26 |
| Inventory Turnover Ratio | 6.99 | 5.49 | 5.4 | 4.03 | 4.11 |
| Receivables Turnover Ratio | 7.37 | 7.4 | 7.58 | 5.76 | 5.83 |
| Days Sales in Inventory Ratio | 52.22 | 66.48 | 67.59 | 90.57 | 88.81 |
| Receivable Days | 49.53 | 49.32 | 48.15 | 63.37 | 62.61 |
| Capital Turnover Ratio | 3.72 | 3.56 | 2.04 | 1.3 | 1.57 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The coverage ratios present a contrasting picture. While the interest coverage ratio is strong, indicating a comfortable ability to meet interest obligations, the lack of equity dividend coverage is a concern. The strong interest coverage ratio provides financial stability, but the absence of dividend payments may deter investors seeking regular income. Balancing debt obligations with shareholder returns is essential for long-term financial health.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 5.5 | 5.33 | 8.5 | 4 | 7 |
| Equity Dividend Coverage Ratio |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The solvency ratios collectively demonstrate an excellent financial position. The low debt ratio and debt-to-equity ratio, combined with a high equity ratio and low debt-to-asset ratio, indicate a strong reliance on equity financing and minimal debt burden. This suggests the company is financially stable and has a solid foundation to support future growth. The minimal debt reduces financial risk and provides flexibility for strategic investments.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.51 | 0.31 | 0.12 | 0.08 | 0 |
| Debt to Equity Ratio | 1.04 | 0.45 | 0.14 | 0.09 | 0 |
| Equity Ratio | 0.49 | 0.69 | 0.88 | 0.92 | 1 |
| Debt To Asset Ratio | 0.23 | 0.14 | 0.09 | 0.05 | 0 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The liquidity position reflects a mixed performance. While current and quick ratios suggest an ability to meet short-term obligations, the cash ratio indicates limited immediate liquidity. The negative operating cash flow ratio is a significant concern, suggesting operational inefficiencies in generating cash. On the positive side, the current and quick ratios show a reasonable ability to cover short-term liabilities with current and liquid assets. Addressing the negative operating cash flow is crucial for enhancing overall liquidity.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 1.44 | 1.36 | 3.58 | 1.83 | 2.11 |
| Quick Ratio | 0.93 | 0.85 | 2.24 | 1.27 | 1.39 |
| Cash Ratio | 0.17 | 0.16 | 0.65 | 0.44 | 0.55 |
| Operating Cash Flow Ratio | 0.38 | 0.24 | -0.7 | -0.37 | 0.63 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Medico Remedies Ltd | 6.61 | 37.70 | Overvalued | 17.00 | 1.58 | 13.00 |
| 2 | Kilitch Drugs (India) Ltd | 6.61 | 21.54 | Neutral | 37.00 | 9.27 | 30.00 |
| 3 | SMS Lifesciences India Ltd | 6.59 | 21.20 | Undervalued | 45.00 | 70.68 | 19.00 |
| 4 | Infinium Pharmachem Ltd | 6.42 | 26.90 | Neutral | 22.00 | 6.43 | 14.00 |
| 5 | Medicamen Biotech Ltd | 5.73 | 32.19 | Neutral | 20.00 | 6.94 | 10.00 |
| 6 | Aarey Drugs & Pharmaceuticals Ltd | 5.73 | 59.71 | Neutral | 7.00 | 1.40 | 4.00 |
| 7 | Albert David Ltd | 5.63 | -272.47 | Neutral | 5.00 | -2.62 | -1.00 |
| 8 | BPL Ltd | 5.46 | -31.11 | Neutral | -4.82 | -3.00 | -8.55 |
| 9 | Zim Laboratories Ltd | 5.41 | 41.96 | Neutral | 30.00 | 1.11 | 6.00 |
| 10 | Lyka Labs Ltd | 4.77 | -23.98 | Neutral | -4.00 | -9.05 | -10.00 |
| 11 | Nectar Lifescience Ltd | 3.83 | -2.67 | Neutral | -59.00 | -2.95 | -293.00 |
Infinium Pharmachem Ltd's management effectiveness shows a mixed performance. Strong sales growth contrasts with declining recent profit growth and concerning working capital management. A reduction in promoter holding adds to concerns about shareholder alignment, necessitating careful monitoring.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Sales Growth (2021-2025) | ₹71 Cr to ₹156 Cr | Consistent sales growth. |
| PROS | Reduced Borrowings (2020-2025) | ₹9 Cr to ₹0 Cr | Improved financial stability. |
| CONS | Net Profit Decline (2024-2025) | ₹12 Cr to ₹8 Cr | Recent profit growth decline. |
| CONS | Cash Conversion Cycle Increase (2020-2025) | 76 Days to 178 Days | Worsening working capital management. |
Financial Performance & Growth
Infinium Pharmachem's financial performance presents a mixed picture. While sales have grown consistently, profit growth has shown recent declines. Fluctuations in the operating profit margin (OPM) also indicate variability in operational efficiency.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Sales (₹ Cr) | 71 | 99 | 114 | 136 | 156 |
| Sales Growth (%) | 81.59% | 40.54% | 15.23% | 18.75% | 14.80% |
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Profit (₹ Cr) | 3 | 7 | 10 | 12 | 8 |
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| OPM (%) | 7% | 10% | 14% | 14% | 11% |
Capital Efficiency & Returns
Infinium Pharmachem's capital efficiency and returns, as indicated by ROCE, have generally been strong but show a recent decline.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| ROCE (%) | 32% | 38% | 36% | 28% | 16% |
Financial Health & Prudence
Infinium Pharmachem's financial health is supported by a recent reduction in borrowings. However, the company has not been distributing profits to shareholders.
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Borrowings (₹ Cr) | 9 | 11 | 23 | 29 | 11 | 0 |
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Dividend Payout (%) | 0% | 0% | 0% | 0% | 0% | 0% |
Strategic & Operational Indicators
Infinium Pharmachem faces challenges in working capital management, as indicated by the increasing cash conversion cycle.
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Cash Conversion Cycle (Days) | 76 | 43 | 78 | 108 | 126 | 178 |
Shareholding & Ownership Structure
Infinium Pharmachem's promoter holding has decreased, which may impact investor confidence.
| Metric | Mar 2024 | Mar 2025 |
|---|---|---|
| Promoter Holding (%) | 73.05% | 65.24% |
The risk assessment for Infinium Pharmachem Ltd indicates moderate concern. The absence of accounting red flags is a positive sign, but segment performance volatility and an increasing cash conversion cycle present challenges. The company's financial health benefits from reduced borrowings, but declining profit growth and reduced promoter holding warrant attention.
Segment performance volatility
Fluctuations in quarterly sales and profit indicate some level of variability in segment performance.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 10205.98Bullish
- SMA 20205.63Bullish
- SMA 50201.17Bullish
- EMA 10206.61Bullish
- EMA 20205.18Bullish
- EMA 50204.07Bullish
- DEMA 10208.22Bullish
- DEMA 20207.36Bullish
- DEMA 50203.37Bullish
- TEMA 10208.83Bullish
- TEMA 20208.46Bullish
- TEMA 50205.48Bullish
- MACD1.67Bullish
- ADX17.70Weak Trend
- IndicatorValueSignal
- RSI71.59Overbought
- CCI272.91Overbought
- ROC 92.37Bullish
- ROC 143.68Bullish
- ROC 255.78Bullish
- Stoch K80.39Overbought
- Stoch D56.43Neutral
- IndicatorValueSignal
- BB Upper209.84Overbought
- BB Middle205.64Neutral
- BB Lower201.43Neutral
- ATR1.60High Volatility
- IndicatorValueSignal
- MFI86.66Overbought
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 10206.23Bullish
- SMA 20202.57Bullish
- SMA 50204.88Bullish
- EMA 10206.34Bullish
- EMA 20204.55Bullish
- EMA 50205.12Bullish
- DEMA 10208.97Bullish
- DEMA 20206.11Bullish
- DEMA 50202.53Bullish
- TEMA 10209.93Bullish
- TEMA 20208.83Bullish
- TEMA 50202.67Bullish
- MACD1.52Bullish
- ADX15.68Weak Trend
- IndicatorValueSignal
- RSI63.68Neutral
- CCI140.93Overbought
- ROC 94.19Bullish
- ROC 145.78Bullish
- ROC 255.75Bullish
- Stoch K92.22Overbought
- Stoch D83.44Overbought
- IndicatorValueSignal
- BB Upper212.32Neutral
- BB Middle202.57Neutral
- BB Lower192.82Neutral
- ATR2.81Low Volatility
- IndicatorValueSignal
- MFI83.84Overbought
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10203.17Bullish
- SMA 20203.27Bullish
- SMA 50208.44Bullish
- EMA 10204.94Bullish
- EMA 20204.75Bullish
- EMA 50207.00Bullish
- DEMA 10206.72Bullish
- DEMA 20203.39Bullish
- DEMA 50204.64Bullish
- TEMA 10209.22Bullish
- TEMA 20204.73Bullish
- TEMA 50N/AN/A
- MACD-0.60Bullish
- ADX19.93Weak Trend
- IndicatorValueSignal
- RSI57.21Neutral
- CCI79.23Neutral
- ROC 98.18Bullish
- ROC 140.48Bullish
- ROC 25-1.61Bearish
- Stoch K84.72Overbought
- Stoch D79.13Neutral
- IndicatorValueSignal
- BB Upper215.00Neutral
- BB Middle203.27Neutral
- BB Lower191.54Neutral
- ATR5.01High Volatility
- IndicatorValueSignal
- MFI75.06Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10202.86Bullish
- SMA 20207.12Bullish
- SMA 50210.17Bearish
- SMA 100210.97Bearish
- SMA 200228.07Bearish
- EMA 10204.63Bullish
- EMA 20206.17Bullish
- EMA 50208.86Bullish
- EMA 100214.14Bearish
- EMA 200226.30Bearish
- DEMA 10203.70Bullish
- DEMA 20203.45Bullish
- DEMA 50205.03Bullish
- DEMA 100201.58Bullish
- DEMA 200206.38Bullish
- TEMA 10205.21Bullish
- TEMA 20202.29Bullish
- TEMA 50206.12Bullish
- TEMA 100203.79Bullish
- TEMA 200194.94Bullish
- MACD-2.02Bullish
- ADX30.55Strong Trend
- IndicatorValueSignal
- RSI52.70Neutral
- CCI-0.76Neutral
- ROC 14-0.80Bearish
- ROC 25-1.96Bearish
- Stoch K58.80Neutral
- Stoch D46.83Neutral
- IndicatorValueSignal
- BB Upper219.39Neutral
- BB Middle207.12Neutral
- BB Lower194.85Neutral
- ATR7.83High Volatility
- IndicatorValueSignal
- MFI58.77Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 20210.46Bearish
- SMA 50234.11Bearish
- EMA 20212.95Bearish
- EMA 50228.72Bearish
- DEMA 20202.00Bearish
- DEMA 50210.78Bearish
- TEMA 20203.87Bearish
- TEMA 50197.11Bearish
- MACD-7.72Bullish
- ADX28.98Strong Trend
- IndicatorValueSignal
- RSI37.97Neutral
- CCI-105.85Oversold
- ROC 14-11.96Bearish
- ROC 25-13.59Bearish
- Stoch K43.75Neutral
- Stoch D57.45Neutral
- IndicatorValueSignal
- BB Upper225.36Neutral
- BB Middle210.46Neutral
- BB Lower195.57Oversold
- ATR15.13High Volatility
- IndicatorValueSignal
- MFI27.22Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 6212.51Bullish
- SMA 12238.88Bearish
- SMA 24255.54Bearish
- EMA 6218.08Bearish
- EMA 12230.99Bearish
- EMA 24235.89Bearish
- DEMA 6205.63Bullish
- DEMA 12214.49Bearish
- DEMA 24N/AN/A
- TEMA 6207.00Bullish
- TEMA 12201.63Bullish
- TEMA 24N/AN/A
- MACDN/AN/A
- ADX44.12Strong Trend
- IndicatorValueSignal
- RSI56.79Neutral
- CCIN/AN/A
- ROC 25-2.84Bearish
- ROC 50N/AN/A
- Stoch KN/AN/A
- Stoch DN/AN/A
- IndicatorValueSignal
- BB Upper336.19Neutral
- BB Middle258.02Neutral
- BB Lower179.86Neutral
- ATR41.73Low Volatility
- IndicatorValueSignal
- MFI40.68Neutral